October 2, 2023The FDA’s newly proposed rules would regulate all in vitro diagnostic products as medical devices if enacted. ARUP believes additional FDA oversight would disrupt the diagnostic testing market.
March 5, 2024Nearly 85% of respondents to an ARUP survey believe the FDA’s proposed rule to regulate lab-developed tests will negatively impact their labs. Only 3% believe they have the financial resources to
January 10, 2024After wrapping up her education in plant biology, Dipanwita Banerjee, MS, took some time off to see the world and start a family. She later returned to the laboratory environment at ARUP.
June 23, 2023Valerie Collier, MS, CGC, will present insights on the DEX MolDx program and how to submit Z-Code applications under new private payer Z-Code requirements as an expert panelist in an upcoming webinar.
April 24, 2024A new partnership between ARUP and connectivity provider ELLKAY aims to give health systems the testing support, guidance, and technology needed to establish or expand lab outreach operations.
November 10, 2023ARUP has gained a Conformité Européenne (CE) mark for AAV5 DetectCDx™ single-site use. The test will aid in determining the eligibility of non-U.S. patients for a new hemophilia A gene therapy.